Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 4Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 24Colorectal Neoplasms 19Rectal Neoplasms 11Stomach Neoplasms 9Colonic Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Carcinoma, Hepatocellular 7Neoplasm Metastasis 6Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Liver Neoplasms 5Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Osteosarcoma 4Esophageal Neoplasms 4Cholangiocarcinoma 4Peritoneal Neoplasms 3Ovarian Neoplasms 3Neuroblastoma 3Multiple Myeloma 3Lung Neoplasms 3Locally Advanced Rectal Cancer 3Kidney Neoplasms 3Inflammatory Breast Neoplasms 3Turcot syndrome 2Sarcoma 2Pancreatic Neoplasms 2Nasopharyngeal Carcinoma 2Head and Neck Neoplasms 2Glioblastoma 2

Interventions

Fluorouracil 3Cyclophosphamide 3pegfilgrastim 2Paclitaxel 2Immunoenzyme Techniques 2Epirubicin 2Chemotherapy, Adjuvant 2Biopsy 2Bevacizumab 2Amplified Fragment Length Polymorphism Analysis 2orantinib 1eribulin 1Zoledronic Acid 1Therapeutics 1Taxes 1Sorafenib 1Radiotherapy 1Radioimmunodetection 1Pyridoxine 1Psychiatric Rehabilitation 1Neoadjuvant Therapy 1Methotrexate 1Magnetic Resonance Spectroscopy 1Immunologic Techniques 1Ibandronic Acid 1Gene Rearrangement 1Gene Expression Profiling 1Flow Cytometry 1Drug Screening Assays, Antitumor 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Breast Neoplasms, Male × Neoadjuvant Therapy × Clear all
NCT01093235 2010-03-25

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
800 enrolled
Breast

Breast Neoplasms, Postoperative Complications, Breast Neoplasms, Male, Inflammatory Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡